Plasmids carrying the Epstein-Barr virus (EBV) latent gene obtained with these EBV-based vectors were compared EBNA1 and the EBV latent origin of replication (oriP) stay with another plasmid, not carrying EBNA1 and oriP. cDNAs in transfected human cells as autonomously replicating coding for GM-CSF, IL6, TNF␣, the chloramphenicolacetylextrachromosomal genetic units. They thus might reptransferase (CAT) and the -galactosidase (lacZ) gene resent a suitable tool for cytokine gene introduction into were transfected into the EBV-positive Burkitt's lymphoma human tumor cells with the prospect of therapeutic anticell line BL60 and the EBV-negative B cell lymphoma cell tumor vaccination. The aim of this study was to analyze line BJA-B. EBV-derived vectors permitted a high, host cell whether such plasmids permit stable and efficient independent transfection efficiency and high and host cell expression of cytokine genes in human non-Hodgkin lymindependent levels of expression. After removal of the phoma cells. We tested physical stability and expression selection pressure (hygromycin B) cytokine expression levels of plasmids carrying EBNA1 and oriP for episomal could be detected for several weeks in vitro and in vivo maintenance, immunoglobulin light chain enhancer but, however, declined continuously. These experiments elements for augmentation of expression, and cytokine or suggest that episomal BC-derived vectors represent an marker genes after introduction into human NHL cell lines effective tool for cytokine gene transfer in human lymin vitro and in vivo after inoculation into nude mice. Data phoma cells.